The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of a 22-gene epithelial-mesenchymal transition (EMT) prognostic signature in clear cell renal cell carcinoma.
 
Brittney Cotta
No Relationships to Disclose
 
Srinivas Nallandhighal
No Relationships to Disclose
 
Judith Stangl-Kremser
No Relationships to Disclose
 
Trinh Pham
No Relationships to Disclose
 
Jeffrey J. Tosoian
Leadership - LynxDx
Stock and Other Ownership Interests - LynxDx
Consulting or Advisory Role - LynxDx
 
Kathryn Marchetti
No Relationships to Disclose
 
Joel Berends
No Relationships to Disclose
 
Mahir Maruf
No Relationships to Disclose
 
Scott A. Tomlins
Employment - Strata Oncology
Leadership - Strata Oncology
Stock and Other Ownership Interests - Javelin Oncology; Strata Oncology
Consulting or Advisory Role - Astellas Medivation; Janssen; Strata Oncology
Research Funding - Astellas Medivation (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent issued to Strata Oncology related to MSI determination and checkpoint inhibitor benefit.; I am a co-inventor on a patent issued to the University of Michigan on ETS gene fusions in prostate and am included in the royalty stream. The diagnostic field of use was licensed to Hologic/Gen-Probe (who sublicensed some rights to Ventana/Roche) and is
Travel, Accommodations, Expenses - Genzyme; Strata Oncology
 
Todd Matthew Morgan
Consulting or Advisory Role - Blue Earth Diagnostics; Myriad Genetics; Stratify Genomics; TERUMO
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)
 
Ganesh S. Palapattu
Stock and Other Ownership Interests - NantWorks
Consulting or Advisory Role - Janssen Scientific Affairs; SynDevRx
Research Funding - Minomic
Patents, Royalties, Other Intellectual Property - implantable nanotechnology for long term testosterone delivery functionalized fiducial marker for drug delivery
 
Eman Adbulfatah
No Relationships to Disclose
 
Aaron M. Udager
No Relationships to Disclose
 
Simpa Salami
Consulting or Advisory Role - Bayer; Springer Nature